Related Experiment Videos
Bacteraemia in man and animals: an overview.
1Disease Investigation Laboratory, Indian Veterinary Research Institute, Regional Station, Palampur, Himachal Pradesh, India.
Veterinary Research Communications
|January 1, 1991
Summary
Bacteraemia, or bacteria in the blood, requires prompt detection. Monoclonal antibodies targeting lipid A show promise for treating bacteraemia and septic shock in humans and animals.
Area of Science:
- Clinical Microbiology
- Immunology
- Veterinary Medicine
Background:
- Bacteraemia involves bacteria entering the bloodstream, a common event in systemic infections in humans and animals.
- Early identification of causative agents is crucial for effective clinical management.
- Diverse microorganisms can cause bacteraemia, leading to varied clinical outcomes.
Purpose of the Study:
- To highlight the importance of prompt detection of bacteraemia's etiological agents.
- To discuss current diagnostic methods for bacteraemia in humans and the lack of defined protocols in animals.
- To explore potential therapeutic strategies for bacteraemia and septic shock.
Main Methods:
- Review of conventional and improved methods for bacteraemia detection in humans.
- Discussion of the challenges in diagnosing bacteraemia in animals.
- Evaluation of monoclonal antibodies against lipid A as a therapeutic approach.
Main Results:
- A wide range of organisms are associated with bacteraemia.
- Prompt detection is vital for successful treatment outcomes.
- Monoclonal antibodies targeting lipid A demonstrate significant therapeutic potential.
Conclusions:
- Effective management of bacteraemia relies on rapid etiological agent identification.
- Further research is needed for standardized diagnostic protocols in veterinary medicine.
- Monoclonal antibody therapy offers a promising avenue for treating bacteraemia and septic shock, particularly in Gram-negative bacterial infections.